Inventor · disambiguated record
Dorian Bevec
Also filed as: BEVEC DORIAN
9 granted patents·84 pending applications·30 citations·filing 2001–2022
83Inventor score
Files withBEVEC DORIAN79MONDOBIOTECH LAB AG3NBO PHARMA LLC2ADVITA LIFESCIENCE AG1ADVITA LIFESCIENCE GMBH1
Top patents by PatentIndex Score
93 records- 0177US7468353B2Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung diseasesMONDOBIOTECH LAB ANSTALT·Filed 2004·Granted Dec 23, 2008·15 cites·15 claims
- 0270US8349805B2Use of Gonadorelin as a therapeutic agentMONDOBIOTECH LAB AG·Filed 2008·Granted Jan 8, 2013·3 cites·4 claims
- 0370US2010190713A1Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0470US2010204140A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0570US2010184708A1Use of gly-pro-glu-oh (gpe) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0670US2010204111A1Astressin and beta- endorphin for use as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0770US2010234306A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0870US2010197585A1Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0970US2010184698A1Use of a deslorelin and mastoparan as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1070US2010204155A1Use of the peptide sfllr-oh and muramyl dipeptide as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1168US8211856B2Use of somatostatin-14 as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Jul 3, 2012·1 cites·3 claims
- 1268US8193149B2Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicineBEVEC DORIAN·Filed 2008·Granted Jun 5, 2012·1 cites·4 claims
- 1368US8178489B2Formulation for aviptadilBACHER GERALD·Filed 2006·Granted May 15, 2012·2 cites·20 claims
- 1465US2010210553A1Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1565US2010184675A1Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1664US7951778B2Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosisMONDOBIOTECH AG·Filed 2007·Granted May 31, 2011·1 cites·5 claims
- 1764US6849409B2Cellular kinases involved in Cytomegalovirus infection and their inhibitionAXXIMA PHARMACEUTICALS AG·Filed 2001·Granted Feb 1, 2005·7 cites·1 claims
- 1863US2010184704A1Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1963US2010210532A1Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2063US2010210562A1Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2163US2010210558A1Minigastrin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2263US2010184677A1Use of the human pancreatic polypeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2363US2010190716A1Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2463US2010273701A1Use of salusin beta alone or in combination with octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2563US2010190711A1Big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2663US2010204130A1Use of human neuropeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2763US2010173845A1Use of fertirelin and delta-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2863US2010204115A1Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2963US2010210536A1Use of leptin (22-56 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3063US2010197601A1Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3163US2010197608A1Use of melanotrophin-potentiating factor as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3262US2010184679A1Use of a combination of cart peptides as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3362US2010204135A1Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)BEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3462US2010204138A1Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3562US2010197603A1Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infectionsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3662US2010204150A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3762US2010204132A1THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPCBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3862US2010204112A1Use of tyr-w-mif-1 and urocortin 2 as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3962US2010210535A1Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereofBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4062US2010216724A1Use of fibronectin fragment (196-203 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4162US2010210555A1Use of a laminin peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4262US2010204142A1Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4361US2010210554A1Therapeutic uses of gastrin- 1 and g- pen-grgdspcaBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4461US2010210557A1Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4561US2010204156A1Use of thymopentin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4661US2010197602A1Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4761US2010184673A1Use of parathyroid hormone ( 1-34 ) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4860US2010204116A1Use of calcitonin as anti-angiogenic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4960US2010197605A1Therapeutic use of peptide yglf and combination with kvlpvpqBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 5060US2010204157A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dorian Bevec files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →